Filter
602
Filtered Results: 602
Text search:
World
Health
Organization
WHO,
Regional
Office
for
Eastern
Mediterranean
Region
Featured
Recommendations
74
New Publications
121
Language
Document type
No document type
209
Studies & Reports
182
Guidelines
102
Manuals
40
Strategic & Response Plan
36
Situation Updates
11
Fact sheets
9
Training Material
5
Resource Platforms
5
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
Global
64
Africa
21
Syria
20
Middle East and North Africa
18
Western and Central Europe
15
South–East Asia Region
8
Latin America and the Carribbean
7
Eastern Europe
6
Sudan
6
Somalia
6
Pakistan
6
West and Central Africa
5
Yemen
5
Afghanistan
4
East and Southern Africa
4
Iraq
4
Myanmar / Burma
4
Iran
3
Nigeria
3
Asia
3
Jordan
3
Eastern Europe and Central Asia
3
Lebanon
3
India
3
North Macedonia
2
Thailand
2
Ukraine
2
Turkey
2
Ghana
2
China
2
Saudi Arabia
2
Bangladesh
2
South Africa
2
Ethiopia
2
Libya
2
Nepal
1
Kenya
1
Benin
1
Sierra Leone
1
Cameroon
1
Albania
1
Morocco
1
Qatar
1
Philippines
1
USA
1
Cambodia
1
Venezuela
1
Croatia
1
Tanzania
1
Western Pacific Region
1
Paraguay
1
Tunisia
1
Uganda
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
South Sudan
1
Liberia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
88
Countries
84
Public Health
67
Women & Child Health
53
Key Resources
39
Capacity Building
15
Pharmacy & Technologies
8
Toolboxes
Mental Health
61
COVID-19
60
Rapid Response
39
Planetary Health
39
NTDs
35
TB
34
HIV
32
Refugee
27
AMR
26
Global Health Education
24
Caregiver
21
NCDs
21
Conflict
21
Disability
15
Pharmacy
14
Polio
9
Malaria
8
Cholera
6
Zika
6
Ebola & Marburg
5
Health Financing Toolbox
4
Natural Hazards
3
Specific Hazards
2
Social Ethics
1
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours f...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
GO pre-deployment training: participant handbook
recommended
This is a pre-deployment training, tailored specially to the Ebola outbreak in West Africa, offered to WHO personnel, consultants, and key partners. The material covered in modules 1-4 is applicable and useful to frontline response workers, national and international. Only Module 5, which focuses on...
A review of proactive risk assessment and risk management practices to ensure the safety of drinking-water
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
The report provides a global knowledge base on suicide and suicide attempts as well as actionable steps for countries based on their current resources and context to move forward in suicide prevention.
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
